EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 147 filers reported holding EAGLE PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $8,819,000 | -10.4% | 173,202 | -1.8% | 0.26% | -16.0% |
| Q3 2021 | $9,843,000 | +17.7% | 176,462 | -9.7% | 0.31% | +24.4% |
| Q2 2021 | $8,361,000 | +1.5% | 195,340 | -1.0% | 0.25% | -0.4% |
| Q1 2021 | $8,240,000 | -9.6% | 197,403 | +0.9% | 0.25% | -14.8% |
| Q4 2020 | $9,113,000 | +8.3% | 195,679 | -1.3% | 0.29% | -5.8% |
| Q3 2020 | $8,418,000 | -12.4% | 198,169 | -1.0% | 0.31% | -17.0% |
| Q2 2020 | $9,608,000 | +9.0% | 200,246 | +4.5% | 0.37% | -10.2% |
| Q1 2020 | $8,813,000 | -22.0% | 191,584 | +1.9% | 0.41% | +10.7% |
| Q4 2019 | $11,294,000 | +6.9% | 187,989 | +0.7% | 0.37% | +5.7% |
| Q3 2019 | $10,561,000 | -3.6% | 186,689 | -5.1% | 0.35% | -1.1% |
| Q2 2019 | $10,956,000 | +4.9% | 196,759 | -4.8% | 0.36% | +5.6% |
| Q1 2019 | $10,441,000 | +19.9% | 206,784 | -4.3% | 0.34% | +10.1% |
| Q4 2018 | $8,710,000 | -19.3% | 216,187 | +38.9% | 0.31% | -3.2% |
| Q3 2018 | $10,788,000 | -10.6% | 155,609 | -2.4% | 0.32% | -11.7% |
| Q2 2018 | $12,063,000 | +211.9% | 159,440 | +227.1% | 0.36% | +172.0% |
| Q4 2016 | $3,867,000 | – | 48,739 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 94,922 | $4,063,000 | 1.33% |
| Smith, Graham & Co., Investment Advisors, LP | 277,572 | $11,880,000 | 1.05% |
| Krensavage Asset Management, LLC | 70,804 | $3,030,000 | 1.03% |
| BRANDES INVESTMENT PARTNERS, LP | 716,873 | $30,682,000 | 0.68% |
| GLOBEFLEX CAPITAL L P | 42,357 | $1,813,000 | 0.33% |
| Zebra Capital Management LLC | 6,472 | $277,000 | 0.32% |
| Capital Impact Advisors, LLC | 19,276 | $825,000 | 0.27% |
| Hein Park Capital Management LP | 31,977 | $1,369,000 | 0.26% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 195,340 | $8,361,000 | 0.25% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,027,000 | 0.15% |